Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hang Su

Showing results (811-820 of 830) with videos related to

Pageof 83
Sort By:
Ejhaem|February 23, 2023
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group databaseXuan Zheng, Bao-Lin Qu, Xin Liu, et al.
American Journal of Hematology|May 26, 2020
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group studyShu-Nan Qi, Yong Yang, Yu-Jing Zhang, et al.
Haematologica|March 23, 2023
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG databaseXin Liu, Li-Ling Zhang, Bao-Lin Qu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2025
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group DatabaseKe Su, Xiao-Rong Hou, Qiu-Zi Zhong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 5, 2025
Single-Cell and Spatial Transcriptomic Profiling of Penile Squamous Cell Carcinoma Reveals Dynamics of Tumor Differentiation and Immune MicroenvironmentHongjian Song, Zhichao Tong, Guixiang Xie, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2021
Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphomaDan Liu, Chunguang Ma, Ping Lu, et al.
Therapeutic Advances in Medical Oncology|October 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphomaFei Luo, Qiu-Zi Zhong, Xin Liu, et al.
Nature Communications|July 4, 2019
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized MicePrasanta K Dash, Rafal Kaminski, Ramona Bella, et al.
Nature Biotechnology|September 25, 2023
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responsesMenglin Wang, Benoit Rousseau, Kunyu Qiu, et al.
Journal of Hematology & Oncology|April 18, 2020
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphomaYuankai Shi, Yongping Song, Yan Qin, et al.
Pageof 83

Showing results (811-820 of 830) with videos related to

Sort By:
Pageof 83
Ejhaem|February 23, 2023
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group databaseXuan Zheng, Bao-Lin Qu, Xin Liu, et al.
American Journal of Hematology|May 26, 2020
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group studyShu-Nan Qi, Yong Yang, Yu-Jing Zhang, et al.
Haematologica|March 23, 2023
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG databaseXin Liu, Li-Ling Zhang, Bao-Lin Qu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2025
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group DatabaseKe Su, Xiao-Rong Hou, Qiu-Zi Zhong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 5, 2025
Single-Cell and Spatial Transcriptomic Profiling of Penile Squamous Cell Carcinoma Reveals Dynamics of Tumor Differentiation and Immune MicroenvironmentHongjian Song, Zhichao Tong, Guixiang Xie, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2021
Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphomaDan Liu, Chunguang Ma, Ping Lu, et al.
Therapeutic Advances in Medical Oncology|October 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphomaFei Luo, Qiu-Zi Zhong, Xin Liu, et al.
Nature Communications|July 4, 2019
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized MicePrasanta K Dash, Rafal Kaminski, Ramona Bella, et al.
Nature Biotechnology|September 25, 2023
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responsesMenglin Wang, Benoit Rousseau, Kunyu Qiu, et al.
Journal of Hematology & Oncology|April 18, 2020
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphomaYuankai Shi, Yongping Song, Yan Qin, et al.
Pageof 83